LISA GAVRONSKY: Open Payments
NPI 1578968095 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,103 in 92 payments from 18 companies in 2025. Trend: 2023 $995 · 2024 $2,355 · 2025 $2,103
Food & beverage: $1,994Education: $110
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 16 | $315 |
| Janssen Biotech, Inc. | 9 | $275 |
| UCB, Inc. | 6 | $264 |
| Organon LLC | 8 | $213 |
| ABBVIE INC. | 14 | $204 |
| LEO Pharma Inc. | 8 | $203 |
| Arcutis Biotherapeutics, Inc. | 4 | $73 |
| Lilly USA, LLC | 3 | $70 |
| E.R. Squibb & Sons, L.L.C. | 3 | $70 |
| Almirall LLC | 3 | $62 |
Products named: OPZELURA, TREMFYA, Bimzelx, VTAMA, SKYRIZI, ANZUPGO, ADBRY, Zoryve.
Industry payments across NY — which companies pay providers there.
